ReviewClinical lymphoma, myeloma & leukemia2015

Three newly approved drugs for chronic lymphocytic leukemia: incorporating ibrutinib, idelalisib, and obinutuzumab into clinical practice.

David S Sanford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.